We are live on ! Find out more
BL

Bleichroeder LP Portfolio holdings

AUM $559M Turnover 17.24%
1-Year Est. Return 83.7%
This Fund
S&P 500
This Quarter Est. Return
-9.26%
1 Year Est. Return
+83.7%
3 Year Est. Return
+202.15%
5 Year Est. Return
+208.71%
10 Year Est. Return
–
AUM
$406M
AUM Growth
-$87M
Cap. Flow
-$33.8M
Cap. Flow %
-8.33%
Top 10 Hldgs %
79.53%
Holding
86
New
3
Increased
3
Reduced
4
Closed
12
Avg Time Held
2.6 years
Top 10 Avg Time Held
1.9 years
Top 20 Avg Time Held
1.9 years

Sector Composition

Rank Sector Weight
1 Healthcare 21.44%
2 Miscellaneous 20.24%
3 Consumer Discretionary 19%
4 Industrials 15.46%
5 Materials 10.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
GLD icon
1
SPDR Gold Trust
GLD
$141B
$81.4M 20.07%
475,000
– –
2019 Q4
15 quarters
BC icon
2
Brunswick
BC
$4.21B
$77.1M 19%
975,636
– –
2020 Q1
14 quarters
LIN icon
3
Linde
LIN
$229B
$43.4M 10.7%
116,564
– –
2019 Q4
15 quarters
INVE icon
4
INVE Technologies, Inc. Common Stock
INVE
$55.3M
$24.3M 6%
2,884,495
– –
2019 Q4
15 quarters
FNA icon
5
DELISTED
Paragon 28, Inc.
FNA
$22.1M 5.45%
1,763,339
– –
2023 Q2
1 quarter
GPGI icon
6
GPGI Inc
GPGI
$3.52B
$19.3M 4.75%
3,599,298
– –
2022 Q1
6 quarters
IVAC icon
7
DELISTED
Intevac Inc
IVAC
$15.7M 3.86%
5,039,023
– –
2019 Q4
15 quarters
MRNS icon
8
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$15.1M 3.71%
1,872,463
– –
2020 Q1
14 quarters
SPGI icon
9
S&P Global
SPGI
$125B
$14.6M 3.6%
40,000
– –
2019 Q4
15 quarters
MDXH icon
10
MDxHealth
MDXH
$55.4M
$9.68M 2.39%
3,458,333
– –
2021 Q4
7 quarters
PROK icon
11
ProKidney
PROK
$305M
$9.16M 2.26%
2,000,000
– –
2022 Q3
4 quarters
BX icon
12
Blackstone
BX
$86.8B
$8.57M 2.11%
80,000
– –
2019 Q4
15 quarters
INSM icon
13
Insmed
INSM
$21.4B
$8.21M 2.02%
325,000
– –
2023 Q1
2 quarters
DUOT icon
14
Duos Technologies
DUOT
$172M
$6.59M 1.62%
1,283,162
– –
2020 Q1
14 quarters
DRRX icon
15
DELISTED
DURECT Corp
DRRX
$6.57M 1.62%
2,637,965
– –
2019 Q4
15 quarters
OPTN icon
16
DELISTED
OptiNose
OPTN
$4.98M 1.23%
269,675
– –
2021 Q4
7 quarters
IDN icon
17
Intellicheck
IDN
$44.8M
$4.67M 1.15%
2,073,583
– –
2019 Q4
15 quarters
JPM icon
18
JPMorgan Chase
JPM
$886B
$4.35M 1.07%
30,000
– –
2019 Q4
15 quarters
MIST icon
19
Milestone Pharmaceuticals
MIST
$98.8M
$4.11M 1.01%
1,326,085
– –
2021 Q4
7 quarters
AXP icon
20
American Express
AXP
$210B
$3.73M 0.92%
25,000
– –
2019 Q4
15 quarters
TV icon
21
Televisa
TV
$1.32B
$3.05M 0.75%
1,000,000
– –
2021 Q2
9 quarters
BLUE icon
22
DELISTED
bluebird bio
BLUE
$2.74M 0.67%
+45,000
New +$3.16M
2023 Q3
0 quarters
LIQT icon
23
LiqTech
LIQT
$12.2M
$2.17M 0.53%
556,974
+541
+0.1% +$1.98K
2020 Q1
14 quarters
CUE icon
24
Cue Biopharma
CUE
$129M
$1.74M 0.43%
25,168
– –
2019 Q4
15 quarters
BRFH icon
25
Barfresh Food Group
BRFH
$10.2M
$1.53M 0.38%
800,287
– –
2022 Q1
6 quarters

Similar funds

Bleichroeder LP's Q3 2023 Portfolio in Review

As of Q3 2023, Bleichroeder LP held 86 positions worth $406M, down 18% from $493M the previous quarter. Its ten largest holdings account for 80% of the portfolio.

Bleichroeder LP withdrew a net $33.8M in Q3 2023, closing 12 positions and reducing 4 holdings. Its most notable exit was Corsair Partnering Corporation, an estimated $12.9M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 21% of assets, down from 24% a quarter earlier, followed by Miscellaneous and Consumer Discretionary.

Against the trend, Bleichroeder LP opened a new position in bluebird bio worth $2.74M.

  • Bleichroeder LP's largest Q3 2023 buy was bluebird bio: 45,000 shares worth $2.74M.
  • Bleichroeder LP added most to Curis in Q3 2023, an estimated $161K increase.
  • Bleichroeder LP's biggest Q3 2023 reduction was Liberty Media Corporation Series C Liberty SiriusXM Common Stock, cutting an estimated $390K.
  • Bleichroeder LP fully exited Corsair Partnering Corporation in Q3 2023, selling an estimated $12.9M.
  • Bleichroeder LP's ten largest holdings make up 80% of its $406M portfolio in Q3 2023.
  • Bleichroeder LP opened 3 new positions and closed 12 in Q3 2023.
  • Bleichroeder LP's portfolio value fell 18% quarter-over-quarter to $406M.

Based on Bleichroeder LP's 13F filing for Q3 2023, filed 9 Nov 2023.